A new test to help select colorectal cancer therapy is the first in a menu of rapid cartridge-based tests the firm is planning to support cancer testing.

Agilent Technologies recently reported fiscal Q3 2025 earnings and revenue that came in above analyst expectations, leading the company to raise its full-year revenue guidance to between US$6.91 ...